PTEN and neoplasm: PD-L1 is expressed on various cell types including T cells, B cells, NK cells, and tumor cells, the expression of which is driven by cytokines (IFN-γ) dependent and independent mechanisms, and the latter involves PTEN deletion, anaplastic lymphoma kinase (ALK) and EGFR mutation (65–67).